Pharmacokinetics of indinavir at 800, 600, and 400 milligrams administered with ritonavir at 100 milligrams and efavirenz in ethnic chinese patients infected with human immunodeficiency virus.

about

Pharmacokinetics of darunavir at 900 milligrams and ritonavir at 100 milligrams once daily when coadministered with efavirenz at 600 milligrams once daily in healthy volunteers Indinavir: the forgotten HIV-protease inhibitor. Does it still have a role?

P2860

Q33962854-1203E602-304A-4E7D-8E52-6637AFC6085B Q36808038-81C4E3D7-25E4-473B-9858-6497D72EE0C8

P2860

Pharmacokinetics of indinavir at 800, 600, and 400 milligrams administered with ritonavir at 100 milligrams and efavirenz in ethnic chinese patients infected with human immunodeficiency virus.

Item

http://www.wikidata.org/entity/Q37598720

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh

2004年學術文章

@zh-hant

name

Pharmacokinetics of indinavir ...... human immunodeficiency virus.

@en

Pharmacokinetics of indinavir ...... human immunodeficiency virus.

@nl

type

Item

label

Pharmacokinetics of indinavir ...... human immunodeficiency virus.

@en

Pharmacokinetics of indinavir ...... human immunodeficiency virus.

@nl

prefLabel

Pharmacokinetics of indinavir ...... human immunodeficiency virus.

@en

Pharmacokinetics of indinavir ...... human immunodeficiency virus.

@nl

P1476

Pharmacokinetics of indinavir ...... h human immunodeficiency virus

@en

P2093

Anushia Panchalingam

http://www.w3.org/2001/XMLSchema#string

Marline C Yap

http://www.w3.org/2001/XMLSchema#string

Nicholas I Paton

http://www.w3.org/2001/XMLSchema#string

P2860

Therapy with efavirenz plus indinavir in patients with extensive prior nucleoside reverse-transcriptase inhibitor experience: a randomized, double-blind, placebo-controlled trial.

Low-dose ritonavir for protease inhibitor pharmacokinetic enhancement.

The influence of efavirenz on the pharmacokinetics of a twice-daily combination of indinavir and low-dose ritonavir in healthy volunteers.

Diurnal variation of plasma protease inhibitor concentrations.

High indinavir Cmin is associated with higher toxicity in patients on indinavir-ritonavir 800/100 mg twice-daily regimen.

Drug resistance and predicted virologic responses to human immunodeficiency virus type 1 protease inhibitor therapy.

Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team.

Efficacy of a twice-daily antiretroviral regimen containing 100 mg ritonavir/400 mg indinavir in HIV-infected patients.

Continued indinavir versus switching to indinavir/ritonavir in HIV-infected patients with suppressed viral load.

Pharmacokinetics and pharmacodynamics of indinavir with or without low-dose ritonavir in HIV-infected Thai patients.

P304

4476-4478

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.48.11.4476-4478.2004

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Lawrence Soon-U Lee

P577

2004-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15504888

http://www.w3.org/2001/XMLSchema#string

P932

525429

http://www.w3.org/2001/XMLSchema#string

Pharmacokinetics of indinavir at 800, 600, and 400 milligrams administered with ritonavir at 100 milligrams and efavirenz in ethnic chinese patients infected with human immunodeficiency virus.

about

P2860

P2860

Pharmacokinetics of indinavir at 800, 600, and 400 milligrams administered with ritonavir at 100 milligrams and efavirenz in ethnic chinese patients infected with human immunodeficiency virus.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932